What's new

Human medicines European public assessment report (EPAR): Eptifibatide Accord, eptifibatide, Date of authorisation: 11/01/2016, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Eptifibatide Accord, eptifibatide, Date of authorisation: 11/01/2016, Revision: 8, Status: Authorised

May 2, 2025 - 15:46
 0
Human medicines European public assessment report (EPAR): Eptifibatide Accord, eptifibatide, Date of authorisation: 11/01/2016, Revision: 8, Status: Authorised
Human medicines European public assessment report (EPAR): Eptifibatide Accord, eptifibatide, Date of authorisation: 11/01/2016, Revision: 8, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Zoledronic Acid Accord...

Next Article

Southern California Edison likely faces ‘material losses’ from Eaton Fire, CEO says

Related Posts

Opinion/decision on a Paediatric investigation plan (PIP): Rydapt, Midostaurin, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Neoplasms benign, malignant and unspecified (incl cysts and polyps);Oncology, PIP number: P/0068/2024

Opinion/decision on a Paediatric investigation plan (PI...

Apr 25, 2025  0

Human medicines European public assessment report (EPAR): Scemblix, asciminib, Date of authorisation: 25/08/2022, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 22, 2025  0

EU Implementation Guide (IG) on veterinary medicines pr...

Apr 26, 2025  0